01 — At a Glance
The Agrochemical Titan That’s Busy Demerging Itself Into Oblivion
- 52-Week High / Low₹812 / ₹580
- Q3 FY26 Revenue₹12,269 Cr
- Q3 FY26 EBITDA₹2,434 Cr
- Q3 FY26 PAT₹490 Cr
- Q3 FY26 EPS (₹)₹4.70
- Book Value₹378
- Price to Book1.66x
- Dividend Yield0.95%
- Debt / Equity0.94x
- Net Debt (Dec 2025)₹23,317 Cr
The Teaser: UPL just delivered Q3 FY26 revenue of ₹12,269 crore (+12% YoY) with EBITDA margin holding firm at ~20%. Operating PAT grew 45% YoY. But here’s the plot twist that’ll keep you up: they approved a composite scheme on Feb 20, 2026 to demerge the India crop protection business into a separate listed entity called “UPL Global” while UPL becomes the strategic parent. Listing expected in 12–15 months. Advanta seeds is already filing its IPO DRHP. Net debt stands at ₹23,317 crore, leveraged at 2.5x EBITDA — markedly higher than peers, but improving. The company’s restructuring three entities simultaneously like it’s assembling IKEA furniture at 2 AM.
02 — Introduction
The Pesticide Giant Playing 4D Chess With Its Own Organization
Meet UPL Limited — a ₹53,043-crore behemoth that sells crop protection chemicals, seeds, and specialty chemicals across 140+ countries. Incorporated in 1969, listed since 1988, and the 5th largest agrochemical company globally by revenue. They’re present in every continent, own 43 manufacturing plants, and hold 14,000+ product registrations. Think of them as the FedEx of pesticides — just with more debt and a flair for corporate drama.
Q3 FY26 delivered a strong quarter: ₹12,269 crore revenue (+12% YoY), EBITDA margin steady at 20%, and operating PAT growth of 45% after adjusting for prior-year one-off tax reversals. But the headline that’s stealing the show? On Feb 20, 2026, the Board approved a composite scheme to demerge its India crop protection business (UPL Sustainable Agri Solutions, or UPL SAS) and merge it with the global crop protection business (UPL Cayman) to create a pure-play listed entity called “UPL Global.” The appointed date for step one is April 1, 2026. Expected listing: June 2027. Expected shareholder confusion: immediate.
Meanwhile, Advanta (the seeds platform) filed its draft red herring prospectus on Jan 19, 2026 for an IPO via offer-for-sale, with UPL and co-investor KKR selling stakes. The company’s also managing U.S. tariff headwinds, LATAM credit stress, and a working capital cycle that expanded 9 days YoY due to peak season build. It’s like watching a juggler add flaming torches mid-performance.
The Feb 2026 Concall (Management’s Take): “Comfortable and confident in achieving FY26 guidance” of 4–8% revenue growth and 12–16% EBITDA growth. Translation: we’re still uncertain about Q4, but the first three quarters looked solid enough that we’re not lowering our bar.
03 — Business Model: WTF Do They Even Do?
They Make Pesticides. They Sell Seeds. They’re Restructuring Everything.
EduInvesting runs entirely on reader support — ₹360 a year keeps the lights on.
